CD40 and neoplasm: Results indicated that a significant reduction in distant tumor volume (96–98%) occurred with increased survival with increased recruitment of effector T cells leading the authors to conclude anti‐CD40 antibody to be an effective immunoadjuvant with radiation to potentiate abscopal responses.58